Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: September 2013

Cardium Therapeutics Inc. (CXM) Business Strategy Builds on Key Elements, Diverse Portfolio

Posted on September 27, 2013 by MissionIR

Cardium Therapeutics is engaged in the acquisition and development of innovative products that fall within a set range of criterion, focused on products and businesses that have demonstrated their potential to address significant unmet medical needs and having a definable … Continue reading →

Posted in Cardium Therapeutics Inc. CXM | Leave a comment

Away from Wall Street; Noble “X” Conference Celebrates 10th Year by Taking Over Club Med

Posted on September 27, 2013 by MissionIR

To commemorate its tenth annual Noble “X” Conference and kick-off 30 years of business, Noble Financial Capital Markets has reserved the entire 220-acre Club Med Sandpiper Bay resort near Palm Beach Florida. From January 19-22, 2014, Noble “X” will attract … Continue reading →

Posted in Small Cap News | Leave a comment

Targeted Medical Pharma, Inc. (TRGM) Starts Presentation at the Aegis Healthcare Conference

Posted on September 27, 2013 by MissionIR

Targeted Medical Pharma, Inc. is a biotechnology company that develops and distributes prescription medical foods for chronic disease treatment, convenience kits, and generic pharmaceuticals to physicians and pharmacies in the United States and Middle East. The company also provides technical … Continue reading →

Posted in Aegis Conference | Leave a comment

PhotoMedex, Inc. (PHMD) Starts Presentation at the Aegis Healthcare Conference

Posted on September 27, 2013 by MissionIR

PhotoMedex, Inc. is a skin health company that provides integrated disease management and aesthetic solutions to dermatologists, professional aestheticians, and consumers. The company offers products and services that address skin diseases and conditions, including psoriasis and acne, and provides skin … Continue reading →

Posted in Aegis Conference | Leave a comment

Regado Biosciences, Inc. (RGDO) Starts Presentation at the Aegis Healthcare Conference

Posted on September 27, 2013 by MissionIR

Regado Biosciences, Inc. is a biopharmaceutical company discovering and developing antithrombotic drug systems for acute and sub-acute cardiovascular and other indications. The company’s lead product includes REG1, an anticoagulant in clinical trials for use in patients with cardiovascular conditions who … Continue reading →

Posted in Aegis Conference | Leave a comment

Can-Fite BioPharma, Ltd. (CANFY) Starts Presentation at the Aegis Healthcare Conference

Posted on September 27, 2013 by MissionIR

Can-Fite BioPharma, Ltd. is a biotechnology company developing drugs for treating cancer and autoimmune inflammatory diseases. Principally, the company develops CF101, which is in Phase III study for the treatment of psoriasis and has completed Phase II study for the … Continue reading →

Posted in Aegis Conference | Leave a comment

Commtouch Software Ltd. (CTCH) Reports on Exploitative Cybercriminal Activity for its “Security Number of the Month”

Posted on September 27, 2013 by MissionIR

When a national or global news story breaks, readers appreciate having a trustworthy news outlet where they can get accurate, up-to-the-minute information. While most news outlets are committed to providing accurate information, it’s becoming increasingly hard thanks to the amount … Continue reading →

Posted in Small Cap News | Leave a comment

Enzo Biochem, Inc. (ENZ) Starts Presentation at the Aegis Healthcare Conference

Posted on September 27, 2013 by MissionIR

Enzo Biochem, Inc. is an integrated life sciences and biotechnology company that focuses on diagnostic and research products. The company operates in three segments: the Clinical Labs segment offers clinical laboratory tests/procedures used in general patient care; the Life Sciences … Continue reading →

Posted in Aegis Conference | Leave a comment

Atossa Genetics, Inc. (ATOS) Starts Presentation at the Aegis Healthcare Conference

Posted on September 27, 2013 by MissionIR

Atossa Genetics, Inc. is a healthcare company developing and marketing cellular and molecular diagnostic risk assessment products for breast cancer. The company’s diagnostic tests include the ForeCYTE Breast Health Test, which provides personalized information about the 10-year and lifetime risk … Continue reading →

Posted in Aegis Conference | Leave a comment

Trovagene Inc. (TROV) Starts Presentation at the Aegis Healthcare Conference

Posted on September 27, 2013 by MissionIR

Trovagene Inc. (NASDAQ: TROV) develops diagnostic technologies for use in patient/disease screening and monitoring in various medical disciplines. The company’s urine-based testing platform helps to enhance cancer care management and women’s healthcare. The company’s technology is also applied in various … Continue reading →

Posted in Aegis Conference | Leave a comment